Transform Wealth, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 98 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Transform Wealth, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$6,000
-87.5%
33,382
-67.5%
0.00%
-80.0%
Q1 2022$48,000
-18.6%
102,7410.0%0.01%
-16.7%
Q4 2021$59,000
-65.5%
102,7410.0%0.01%
-70.0%
Q3 2021$171,000
-0.6%
102,7410.0%0.02%
-4.8%
Q2 2021$172,000
-50.4%
102,741
-50.0%
0.02%
-70.0%
Q1 2021$347,000
+6.1%
205,4810.0%0.07%
+2.9%
Q4 2020$327,000
+66.0%
205,4810.0%0.07%
+112.5%
Q3 2020$197,000
+50.4%
205,4810.0%0.03%
+45.5%
Q2 2020$131,000
+54.1%
205,4810.0%0.02%
+22.2%
Q1 2020$85,000
-29.2%
205,4810.0%0.02%
-5.3%
Q4 2019$120,000
+16.5%
205,4810.0%0.02%
+5.6%
Q3 2019$103,000
+28.8%
205,4810.0%0.02%
+50.0%
Q2 2019$80,000
-30.4%
205,4810.0%0.01%
-42.9%
Q1 2019$115,000
+42.0%
205,4810.0%0.02%
+23.5%
Q4 2018$81,000
-22.1%
205,4810.0%0.02%
-5.6%
Q3 2018$104,000
-77.0%
205,4810.0%0.02%
-78.0%
Q2 2018$452,000
-35.3%
205,4810.0%0.08%
-38.3%
Q1 2018$699,000
-16.4%
205,4810.0%0.13%
-13.6%
Q4 2017$836,000
+872.1%
205,481
+46.2%
0.15%
+413.3%
Q3 2017$86,000
+17.8%
140,5670.0%0.03%
-63.4%
Q2 2017$73,000
-34.8%
140,5670.0%0.08%
+95.2%
Q1 2017$112,000
-11.8%
140,5670.0%0.04%
-16.0%
Q4 2016$127,000
+17.6%
140,567
-3.4%
0.05%
+8.7%
Q3 2016$108,000
-42.9%
145,567
-0.8%
0.05%
-41.8%
Q2 2016$189,000146,6920.08%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders